Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa F Khouri

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2017
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic SyndromeStefan O Ciurea, Mithun V Shah, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2019
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with LymphomaNeeraj Y Saini, Rima M Saliba, Gabriela Rondon, et al.
Cancer|April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Blood Advances|April 3, 2020
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entityAnkur Varma, Susan C Abraham, Rohtesh S Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched AnalysisNeeraj Saini, Junsheng Ma, Denái R Milton, et al.
Cancer|March 19, 2021
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaElias Jabbour, Koji Sasaki, Nicholas J Short, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2019
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched AnalysisAnkur Varma, Dawen Sui, Denái R Milton, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2017
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic SyndromeStefan O Ciurea, Mithun V Shah, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2019
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with LymphomaNeeraj Y Saini, Rima M Saliba, Gabriela Rondon, et al.
Cancer|April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Blood Advances|April 3, 2020
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entityAnkur Varma, Susan C Abraham, Rohtesh S Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched AnalysisNeeraj Saini, Junsheng Ma, Denái R Milton, et al.
Cancer|March 19, 2021
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaElias Jabbour, Koji Sasaki, Nicholas J Short, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR)Hillard M Lazarus, Jeanette Carreras, Christian Boudreau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2019
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched AnalysisAnkur Varma, Dawen Sui, Denái R Milton, et al.
Pageof 7